Tucker John H 4
4 · scPharmaceuticals Inc. · Filed Jan 23, 2023
Insider Transaction Report
Form 4
Tucker John H
DirectorPresident and CEO
Transactions
- Award
Stock Option (right to buy)
2023-01-19+100,000→ 100,000 totalExercise: $6.14Exp: 2033-01-19→ Common Stock (100,000 underlying) - Award
Common Stock
2023-01-19$6.14/sh+66,665$409,323→ 145,589 total
Footnotes (2)
- [F1]Consists of a restricted stock unit ("RSU") award made pursuant to the ScPharmaceuticals Inc. 2017 Stock Option and Incentive Plan. The RSUs vest as to 25% of the shares underlying the RSUs on each of the first four anniversaries of January 1, 2023, such that the RSUs will be fully vested on January 1, 2027.
- [F2]The option shares vest over a four-year period, at a rate of 25% on January 1, 2024, with the remaining option shares vesting in 36 equal monthly installments thereafter, such that the option shares will be fully vested on January 1, 2027.